About Integra Holdings
Integra Holdings is a venture capital firm founded in 2012. It is primarily based out of Jerusalem, Israel. As of May 2021, Integra Holdings has invested in 13 companies. It primarily invests in Series B round in Israel based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series B round of SpliSense Overall, Integra Holdings portfolio has seen 2 IPOs, namely Mobileye and Exelon. A lot of funds co-invest with Integra Holdings, with names like Cystic Fibrosis Foundation sharing a substantial percentage of its portfolio. Integra Holdings has team of 15 people including 10 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B & Series F
Integra Holdings' List of Top Investments
Integra Holdings has a portfolio of 13 companies. Their most notable investments include Mobileye and Exelon.Their portfolio spans across Israel and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 6 other sectors, across stages such as Series B, Series F stages. Here is the list of top investments by Integra Holdings:1. Mobileye
AI-based system-on-chips for advanced driver assistance systems. The platform provides warnings for collision prevention and mitigation. It uses its proprietary software algorithms and chips to perform detailed interpretations of the visual field to anticipate possible collisions with other vehicles and pedestrians. Its systems work as a third eye for the driver by supporting the driver in performing routine driving tasks, including distance keeping, and adaptive cruise control. It also provides timely warnings, including lane-departure warnings, and forward-collision warnings in dangerous situations.
Key facts about Mobileye
- Founded Year: 1999
- Location: Jerusalem (Israel)
- Annual Revenue: $1.65B as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $530M
- Employee Count: 1,939 as on Jul 01, 2024
- Investors: Wellington, BlackRock and 25 Others
- Latest Funding Round: PE, Jul 07, 2013, $*****
- Highlight: Public
2. Exelon
Provider of energy services with an electric and natural gas distribution. The company is one of the largest operators of nuclear power plants in the United States. It was created in October 2000 by the merger of PECO Energy Company and Unicom, of Philadelphia and Chicago respectively. Producing 521-MW utility-scale & distributed solar power and claims to be the 4th largest solar power producer globally. The company has operations and business activities in 47 states, the District of Columbia, and Canada. The company merged with Constellation Energy Group in March 2012. In 2022, the company recorded annual revenues of $19.07B and a net profit of $2.17B.
Key facts about Exelon
- Founded Year: 2000
- Location: Chicago (United States)
- Annual Revenue: $31.7M as on Dec 31, 2017
- Stage: Public
- Employee Count: 466 as on Dec 31, 2022
- Investors: IDEO CoLab and Integra Holdings
- Latest Funding Round: Post IPO, Apr 24, 2019, $*****
- Highlight: Public
3. SpliSense
Key facts about SpliSense
- Founded Year: 2016
- Location: Jerusalem (Israel)
- Stage: Series B
- Total Funding till date: $28.5M
- Employee Count: 10 as on Jul 01, 2024
- Investors: Orbimed, Cystic Fibrosis Foundation and 2 Others
- Latest Funding Round: Series B, May 13, 2021, $*****
4. HIL Medical
Developer of proton-beam radiotherapy device to treat solid tumors. The company applies particle acceleration and beam delivery approach, combining nano-technology with ultra-high-intensity lasers and ultra-fast magnets to develop proton-therapy systems for cancer treatment.
Key facts about HIL Medical
- Founded Year: 2010
- Location: Jerusalem (Israel)
- Stage: Series C
- Total Funding till date: $3.15M
- Investors: EIC Fund, Integra Holdings and 3 Others
- Latest Funding Round: Grant (prize money), Apr 30, 2023, $*****
Key facts about Nectin Therapeutics
- Founded Year: 2017
- Location: Jerusalem (Israel)
- Stage: Series A
- Total Funding till date: $43M
- Employee Count: 9 as on Jul 01, 2024
- Investors: aMoon, Israel Biotech Fund and 6 Others
- Latest Funding Round: Series A, May 06, 2024, $*****
Integra Holdings' Year-on-Year Investment Trends
Integra Holdings has invested in 13 companies over the last 12 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in SpliSense and most recent follow-on round was in Avraham Pharma.Integra Holdings' Investments by Stage
Integra Holdings has made 2 investments in Series B stage with an average round size of $16.5M and 1 investment in Series F stage with an average round size of $33M.Stage of entry | No. of Investments |
|---|---|
Series B | 2 |
Series F | 1 |
Note: We have considered here, only first round of investments
Integra Holdings' Investments by Sector
Integra Holdings has a diverse portfolio, with companies operating in the Life Sciences and Healthcare. Notably, it has invested in 10 Tech companies, 9 Enterprise (B2B) companies, 3 Software companies and at least 2 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Healthcare | 1 |
Note: We have considered here, only first round of investments
Integra Holdings' Investments by Geography
Integra Holdings has made most investments in Israel (3), followed by United States where it has made 1 investment.Country | No. of Investments |
|---|---|
Israel | 3 |
United States | 1 |
Note: We have considered here, only first round of investments
Integra Holdings' recent investments
Integra Holdings has not made any investment in 2026 so far.Here are the most recent investments by Integra Holdings:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 13, 2021 | Israel | Series B | 9885 | ||
Dec 04, 2017 | United States | Series F | 4639 | [+5] | |
Feb 25, 2016 | Israel | Series B | 5889 | [+3] | |
Sep 17, 2014 | Israel | Series B | 1445 | [+3] |
IPOs and Publicly Listed companies in Integra Holdings' Portfolio
2 of Integra Holdings' portfolio companies have become public. Mobileye got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2022 at marketcap of $16.7B and Exelon got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Integra Holdings' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 26, 2022 | - | - | 6620 | |
Feb 04, 1980 | - | - | 2584 |
Team profile of Integra Holdings
Integra Holdings has a team of 15 members including 10 Partners and 1 Principal located in Israel and United States. Integra Holdings' team does not sit on the board of any company as of now.Here is a list of top team members in Integra Holdings:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | Haifa | - | ||
Partner | Jerusalem | - | ||
Partner | Detroit | - | - | |
Partner | Israel | - | ||
Partner | Jerusalem | - | - | |
Partner | Israel | - | - | |
Partner | Israel | - | - | |
Partner | Israel | - | - | |
Partner | Israel | - | - | |
Principal | Israel | - |
Co-investors of Integra Holdings
Over the past 12 years, 14 investors have co-invested in Integra Holdings's portfolio companies. This includes funds and angels.
- Invested before Integra Holdings: SR One, Orbimed and 6 others have invested in rounds before Integra Holdings. There is 1 company where SR One has invested before Integra Holdings and 1 company where Orbimed has invested before Integra Holdings.
- Top Co-investors of Integra Holdings: 6 investors entered a company along with Integra Holdings. These include investors like Cystic Fibrosis Foundation (1 company).
Recent News related to Integra Holdings
•
CF Foundation Invests Up to $8.4M in SpliSense for the Development of Potential Rare Mutation TherapyBusiness Wire•May 13, 2021•SpliSense, Orbimed, Biotel, Integra Holdings and 1 other
•
SpliSense Secures $28.5 Million in Series B FinancingPR Newswire•May 13, 2021•SpliSense, Orbimed, Biotel, Integra Holdings and 3 others
•
InnoCan Entered into the Yissum AgreementCMOCRO•Oct 07, 2019•InnoCan Pharma, Yissum, Evotec, Integra Holdings
•
Cedar Holdings Group Ltd.’s acquisition of Granite Capital S.A.Global Legal Chronicle•May 24, 2018•Cedar Holdings, Integra Holdings
•
Atox Bio Closes $30 Million InvestmentPR Newswire•Dec 04, 2017•Atox Bio, Arix Bioscience, Adams Street Partners, Asahi Kasei and 5 others
•
Temasek Leads $25 Million Investment Round in Integra HoldingsPR Newswire•Sep 27, 2017•Integra Holdings
•
Integra Holdings Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250Sectorpublishingintelligence•May 02, 2017•Integra Holdings
•
•
•
